Try our Advanced Search for more refined results
Mergers & Acquisitions
-
July 15, 2025
FTC Says Merger Penalty Deal In The Works With 7-Eleven
The Federal Trade Commission is inching closer to a settlement with 7-Eleven in its suit seeking to slap the convenience store chain with a $77.5 million penalty for violating a settlement that it inked with the agency in order to get a merger approved back in 2018.
-
July 15, 2025
FTC Still Bans Ex-Pioneer CEO From Exxon Board, For Now
If the current Federal Trade Commission upends Biden-era Democrats' ban on the former CEO of Pioneer from serving on Exxon's board, it will be on the now-Republican-led commission's own volition rather than through a petition by the executive.
-
July 15, 2025
Door Maker Defends Landmark Divestiture Order At 4th Circ.
Steves & Sons Inc. has urged the Fourth Circuit to preserve the first court-ordered divestiture in a private merger challenge, arguing Jeld-Wen's sale of the Pennsylvania factory restored competition in the market for the door skins used to make molded interior doors.
-
July 15, 2025
Kirkland Tops M&A League Tables In First Half Of 2025
Kirkland & Ellis LLP was the top mergers and acquisitions legal adviser both globally and in North America during the first half of 2025, as measured by both value and transaction numbers, league table data from GlobalData showed Tuesday.
-
July 15, 2025
La Caisse Plugs $200M Into PE-Backed Renewa
Infrastructure investor QIC Infrastructure on Tuesday announced that its portfolio company Renewa received a $200 million primary equity commitment from investment group La Caisse.
-
July 15, 2025
Sunnova Seeks OK For $7M In Ch. 11 Sale Incentives To Execs
Bankrupt solar panel giant Sunnova has asked a Texas bankruptcy court for permission to pay up to $7 million in cash incentives to its top executives, contingent on securing higher sale proceeds than its stalking horse bids for certain assets.
-
July 15, 2025
Small Carriers Caught Off Guard By Demand-Free T-Mobile OK
Rural wireless carriers appeared stunned by the feds' recent decision to let T-Mobile absorb most of UScellular without setting new requirements meant to protect their service areas, but they aren't the only ones dismayed by the turn of events.
-
July 15, 2025
2 Firms Guide Cavco's $190M Manufactured Home Co. Buy
Cavco Industries said it has reached an agreement to acquire Houston-based homebuilder American Homestar Corp. and its subsidiaries for $190 million, in a transaction advised by DLA Piper and Jackson Walker LLP.
-
July 15, 2025
Irish Hotel Group Backs €1.4B Sweetened Buyout Bid
Irish hotel group Dalata said Tuesday that it has backed an increased €1.4 billion ($1.6 billion) cash offer from a Scandinavian consortium of property investors, finding that the bid topped its highest market capitalization since it listed in 2014.
-
July 15, 2025
Paul Hastings Adds M&A Specialist From Paul Weiss
Paul Hastings LLP has brought on a Paul Weiss Rifkind Wharton & Garrison LLP partner who specializes in mergers and acquisitions as well as complex transactions for public and private companies and private equity firms, the firm said Tuesday.
-
July 14, 2025
FCC Greenlights Bell Canada's $3.65B Ziply Fiber Deal
The Federal Communications Commission on Monday granted its approval to Canadian communications company BCE Inc.'s planned acquisition of U.S. internet provider Ziply Fiber for about CA$5 billion ($3.65 billion).
-
July 14, 2025
PE-Backed NIQ Global Intelligence Plans $1.1B IPO On NYSE
Private equity-backed consumer research services provider NIQ Global Intelligence on Monday disclosed plans to raise $1.1 billion in its initial public offering.
-
July 14, 2025
Foley & Lardner Brings On Cooley Litigator In San Francisco
Foley & Lardner LLP has added a former Cooley LLP partner to its San Francisco office, bolstering its commercial litigation practice and services for innovative technology and healthcare and life sciences sectors, the firm announced Monday.
-
July 14, 2025
Wachtell Guides Huntington Bancshares On $1.9B Veritex Buy
Huntington Bancshares Inc. said Monday it has agreed to acquire Dallas-based Veritex Holdings Inc. in an all-stock transaction valued at $1.9 billion, deepening the Ohio-based lender's presence in the Texas market.
-
July 14, 2025
Winston & Strawn Hires Ex-Cadwalader Transactions Atty
Winston & Strawn LLP has hired a former Cadwalader Wickersham & Taft LLP partner as a new partner for its transactions and structured finance teams in New York City and Charlotte, North Carolina.
-
July 14, 2025
Kirkland, Wachtell Guide $17.5B Waters-BD Life Sciences Deal
Waters Corp. and Becton Dickinson and Co., or BD, said Monday they will combine BD's Biosciences and Diagnostic Solutions unit with Waters in a $17.5 billion deal using a Reverse Morris Trust structure, in a deal steered by Kirkland & Ellis LLP and Wachtell Lipton Rosen & Katz.
-
July 11, 2025
Courts Face Early Push To Expand Justices' Injunction Ruling
In the two weeks since the U.S. Supreme Court curtailed federal judges' ability to issue universal injunctions, Trump administration attorneys have begun pushing to expand the decision's limits to other forms of relief used in regulatory challenges and class actions. So far, judges don't appear receptive to those efforts.
-
July 11, 2025
Soros Fund Boss Says Radio CEO Can't Sue Him In Conn.
A Soros Fund Management LLC portfolio manager says a radio CEO cannot sue him in Connecticut because he's beyond the state's long-arm jurisdiction, seeking to shake the CEO's claim that he was boxed out of dividends and a potential job after allegedly helping the fund acquire broadcasting company Audacy Inc.
-
July 11, 2025
Google Won't Have To Turn Over EU Ad Tech Settlement Docs
A Virginia federal judge refused a request from the U.S. Department of Justice Friday to force Google to hand over submissions it made to European enforcers when trying to settle their investigation as the sides ready for a remedies trial in the ad tech monopolization case.
-
July 11, 2025
Merck's $10B Pulmonary Power Play Is Among Its Top 5 Deals
When Merck agreed to purchase respiratory disease-focused Verona Pharma PLC for $10 billion, it became one of Merck's largest deals ever, and the pharmaceutical giant made clear that its bet on a potentially transformative pulmonary therapy was much more than a speculative pipeline acquisition.
-
July 11, 2025
FCC Approves T-Mobile's $4.4B UScellular Deal
Federal Communications Commission staff late Friday approved the license transfers needed for T-Mobile to complete its $4.4 billion acquisition of UScellular wireless operations.
-
July 11, 2025
HOA Is Pushing Out Country Club Owner, NC Suit Says
A Florida country club operator asked a North Carolina judge to find that it controls a Charlotte-area country club and golf course within a gated community, alleging that a homeowners association has refused to recognize the company as the club's owner.
-
July 11, 2025
Walgreens Boots Shareholders Approve $24B Sycamore Deal
Walgreens Boots Alliance said Friday its shareholders have approved a plan for the company to be purchased by private equity firm Sycamore Partners, in a transaction with a total value of up to $23.7 billion.
-
July 11, 2025
Better Therapeutics Settles SPAC Suit In Del. For $1M
Defunct telehealth provider Better Therapeutics Inc. has reached a roughly $1 million settlement with a shareholder to end a Delaware Chancery Court suit challenging its take-public merger, according to court filings.
-
July 11, 2025
Cancer-Focused BridgeBio's $949M SPAC Deal Gets SEC Nod
Clinical-stage biopharmaceutical company BridgeBio Oncology Therapeutics, advised by Goodwin Procter LLP, and White & Case LLP-led special purpose acquisition company Helix Acquisition Corp. II on Friday revealed that their $949 million merger had been cleared by U.S. regulators.
Expert Analysis
-
3 Del. Bankruptcy Cases Highlight US Trustee Objections
As three recent Delaware bankruptcy cases show, debtors who seek approval of a stalking horse bid protections agreement should be prepared for the U.S. Trustee Office's objections, including if the proposed classification for the bid protections is a superpriority administrative expense claim, says Kyle Arendsen at Squire Patton.
-
How 2025 Is Shaping The Future Of Bank Mergers So Far
Whether the long-anticipated great wave of consolidation in the U.S. banking industry will finally arrive in 2025 remains to be seen, but the conditions for bank mergers are more favorable now than they have been in years, say attorneys at Skadden.
-
Series
Adapting To Private Practice: From SEC To BigLaw
As I adjusted to the multifaceted workflow of a BigLaw firm after leaving the U.S. Securities and Exchange Commission, working side by side with new colleagues on complex matters proved the fastest way to build a deep rapport and demonstrate my value, says Jennifer Lee at Jenner & Block.
-
China High Court Ruling Could Encourage Antitrust Litigation
Practitioners defending U.S. companies in China should take note of a Chinese Supreme Court ruling that plaintiffs can file suits based on either where the alleged action, or where the result of such action, occurred — which will promote civil litigation by minimizing procedural battles over forum selection, says Yang Yang at Leaqual Law Firm.
-
Making The Case For Rest In The Legal Profession
For too long, a culture of overwork has plagued the legal profession, but research shows that attorneys need rest to perform optimally and sustainably, so legal organizations and individuals must implement strategies that allow for restoration, says Marissa Alert at MDA Wellness, Carol Ross-Burnett at CRB Global, and Denise Robinson at The Still Center.
-
4 Ways Women Attorneys Can Build A Legal Legacy
This Women’s History Month, women attorneys should consider what small, day-to-day actions they can take to help leave a lasting impact for future generations, even if it means mentoring one person or taking 10 minutes to make a plan, says Jackie Prester, a former shareholder at Baker Donelson.
-
A Judge's Pointers For Adding Spice To Dry Legal Writing
U.S. District Judge Fred Biery shares a few key lessons about how to go against the grain of the legal writing tradition by adding color to bland judicial opinions, such as by telling a human story and injecting literary devices where possible.
-
Preparing For Disruptions To Life Sciences Supply Chains
Life sciences companies must assess how new and escalating tariffs — combined with other restrictions on cross-border activity singling out pharmaceutical products and medical devices — will affect supply chains, and they should proactively prepare for antitrust and foreign direct investment regulatory review processes, say attorneys at Weil.
-
Mastering The Fundamentals Of Life Sciences Due Diligence
As life sciences transactions continue to gain tremendous momentum, companies participating in these transactions must conduct effective and strategic regulatory due diligence, which involves extensive amounts of information and varies by manifold factors, says Anna Zhao at GunnerCooke.
-
A Close-Up Look At DOJ's Challenge To HPE-Juniper Deal
The outcome of the Justice Department's challenge to Hewlett Packard Enterprise's proposed $14 billion acquisition of Juniper Networks will likely hinge on several key issues, including market dynamics and shares, internal documents, and questions about innovation and customer harm, say attorneys at McDermott.
-
5 Merger Deal Considerations In Light Of The New HSR Rules
Now that the new Hart-Scott-Rodino Act rules are in effect, current priorities include earlier preparation for merging parties, certain confidentiality covenants, and key elements of letters of intent and term sheets, say attorneys at Fried Frank.
-
What FERC Scrutiny Of Directors, Assets Means For Investors
The Federal Energy Regulatory Commission has recently paid dramatically increased attention to appointments of power company directors by investors, and ownership of vertical assets that provide inputs for electric power production and sale — so investors in FERC-regulated entities should be paying more attention to these matters as well, say attorneys at Day Pitney.
-
Opinion
Antitrust Analysis In Iowa Pathologist Case Misses The Mark
An Iowa federal court erred in its recent decision in Goldfinch Laboratory v. Iowa Pathology Associates by focusing exclusively on market impacts and sidestepping key questions that should be central to antitrust standing analysis, says Daniel Graulich at Baker McKenzie.
-
Anticipating Calif. Oversight Of PE Participation In Healthcare
A new bill recently introduced in the California Senate revives last year's attempt to increase oversight of healthcare transactions involving private equity groups and hedge funds, meaning that attorneys may soon need to assess the compliance status of existing management relationships and consider modifying contract terms, says Andrew Demetriou at Husch Blackwell.
-
When Reincorporation Out Of Del. Isn't A Good Idea
While recent high-profile corporate moves out of Delaware have prompted discussion about the benefits of incorporation elsewhere, for many, remaining in the First State may be the right decision due to its deep body of business law, tradition of nonjury trials and other factors, say attorneys at Goodwin.